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Protection Against Chemical-Induced
Lung Injury by Inhibition of Pulmonary
Cytochrome P-450
by Richard D. Verschoyle* and David Dinsdale*
Protection afforded by trialkyl phosphorothionates against the lung injury caused by trialkyl
phosphorothiolates probably results from the inhibition by the P=S moiety of the thionates, of one
ormorepulmonary cytochrome P-450isozymes. Thearomatichydrocarbonsp-xylene andpseudocumene
also protect against this injury and inhibit some P-450 isozymes, but by a different mechanism.
OOS-Trimethylphosphorothionate and p-xylene were compared as protective agents against the
effect ofOOS-trimethylphosphorothiolate andtwo otherlungtoxinsipomeanoland 1-nitronaphthalene
thatareknowntobeactivatedbycytochromeP-450. Theeffectsoftheseprotectivecompounds, invivo,
on pulmonary cytochrome P-450 activity were also determined. Both compounds inhibited
pentoxyresorufin O-deethylaseactivity, butnotethoxyresorufin O-deethylase. Thephosphorothionate
wasmosteffectiveagainstlunginjurycausedbythephosphorothiolatesand 1-nitronaphthalene, whereas
p-xylene was much more effective against ipomeanol.
(-Naphthoflavone, which inducespulmonary ethoxyresorufin O-deethylase activity, did not protect
againstphosphorothiolate or 1-nitronaphthaleneinjury, anditwas only marginally effective indecreas-
ing the toxicity of ipomeanol.
Introduction
OOS-trimethylphosphorothiolate (OOSMeO) andOSS-
trimethylphosphorodithiolate (OSSMeO) have been
found as impurities in certain organophosphorus
pesticides (1-3). When dosed to rats, they cause lung
enlargement involving early necrosis ofalveolarType I
pneumocytes and the proliferation of alveolar Type II
cells (4).
Incontrast, sublethaldosesoftwoothersystemiclung
toxins 1-nitronaphthalene(1-NN)andipomeanol, selec-
tively damage the nonciliated bronchiolar epithelial
(Clara) cells (5-9). Slightly higher doses, particularly of
1-NN, alsodamagetheadjacent ciliatedcells(9). Neither
ofthesecompoundsinjureT7ype I pneumocytes and do
not induce cell proliferation in the alveoli.
The phosphorothionates, e.g., OOS-trimethylphos-
phorodithionate (OOSMeS), are notlung-specific toxins.
When dosed to rats at 1/50 LD50 dose, 2 hr prior to a
challenge dose ofOOSMeO orOSSMeO, they preventthe
lung damage normally caused by these toxins (10,11).
The aromatic hydrocarbonp-xylene can also prevent
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thislungdamagewhengiven24hrbeforechallengewith
OSSMeO (10).
The trialkylphosphorothiolates, like 1-NN and ipo-
meanol, require activation by the cytochrome P-450
system before they become toxic to the lung(3,6,7,12).
In this preliminary study we have investigated the pro-
tection afforded against each of these toxins by both
aromatic hydrocarbons and OOSMeS. We have also
examined the effect ofthese protective compounds on
the oxidation of pentoxyresorufin and ethoxyre-
sorufin. These substrates are specific for the isozymes
of cytochrome P-450 that are selectively induced by
either phenobarbitone or 3-methylcholanthrene.
Materials and Methods
Animals
Female Wistar-derived rats (LAC:P) weighing 170 to
200g(8-10weeksold)were usedthroughoutthe study.
All rats were housed in an air-conditioned animal room
at20to22ICwitharelativehumidityof40to60%. Oral
dosingwasbyesophagealintubationafterovernightstar-
vation. Ratsweresubsequentlygivenfreeaccesstowater
andstandard(41B)diet. Alltestcompoundsweredosed
by the PO or IP route as solutions in arachis oil (Sigma
Chemical Co. Ltd., Dorset, England). LD50 doses wereVERSCHOYLEAND DINSDALE
calculated by the method of Weil (13), normally using
groups offour rats, and lung weights were determined
asdescribedpreviously(11). Lungswerefixedinsituvia
the trachea, and slices 1 mm thick were prepared for
light and electron microscopy (14).
Chemicals
OOSMeSandOOSMeOweredonatedbyF. C. Churchill
and J. W. Miles (Centers for Disease Control, Atlanta,
GA). OSSMeO was prepared by P. B. Farmer and I. Bird
(MedicalResearchCouncil [MRC], ToxicologyUnit, Sur-
rey). These compounds were all analyzed by E. Bailey
(MRC Toxicology Unit) and found to be > 99% pure.
Ipomeanol (> 99% pure) was donated by M. Boyd
(National Cancer Institute, Bethesda, MD). Ethoxy-
resorufin and pentoxyresorufin were donated by A. G.
Smith (MRC Toxicology Unit) (15). 1-NN (> 99% pure),
f3-naphthoflavone (97% pure), and p-xylene (> 99%
pure) were purchased from Aldrich (Aldrich Chemical
Co. Ltd., Dorset, England). Cytochrome c and NADPH
(tetrasodium salt) were obtained from Sigma (Sigma
ChemicalCo. Ltd., Dorset, England)andpseudocumene
(98% pure) from Beckman (Beckman Ltd., Fullerton,
CA).
Enzyme Assays
For lung microsomal preparation, rats were killed by
decapitation, and homogenates oflung were prepared
(20% in0.05 MThis: 0.154 M KCI, pH 7.4) using an Ilado
X-1020homogenizerat 75% maximum revolutions fora
periodof25sec. Aftercentrifugationat40C(10,OOOgfor
15 min and 100,000g for 60 min) the microsomal pellet
was resuspended in Tris-KCl buffer. All enzyme assays
werecarried outonthedayofmicrosomalpreparation.
The 0-dealkylation ofalkoxyresorufinwasmeasured
fluorimetrically at 37OC by the direct monitoring of
resorufin formation as described by Lubet et al. (16).
NADPH-cytochrome creductase wasdetermined asthe
initialreduction rate(3 minat25IC)ofcytochrome cat
550 nm (17). The protein content of the microsomal
preparationwasmeasuredbyamodificationofLowry's
method (18).
Results and Discussion
The oral administration of both OSSMeO (25 mg/kg)
andOOSMeO(60mg/kg)causedaselectiveirjuryto Iype
I pneumocytes within 24 hr, followed by lung enlarge-
mentandmortalityafter3to5days. Mostdeathsoccur-
red 1 to 2 days after ipomeanol (18 mg/kg IP and 1 to 7
days after 1-NN (299 mg/kg/PO). Ipomeanol (15 and 18
mg/kg IP) and 1-NN (87 mg/kg PO) resulted in damage
to the bronchiolar epithelium within 24 hr, which was
apparentbybothlightandelectronmicroscopy. Damage
was not restricted to the Clara cells at these doses, and
italsoextendedtotheciliatedcells(Fig. IA). Lowerdoses
could be employed to minimize damage to the ciliated
cells, but the threshold forirnury between ciliated and
nonciliated cells, particularly for 1-NN, was very fine.
Ipomeanoland 1-NNalsoinducedslightalveolaredema
thatwasonlydetectablebyelectronmicroscopy. Afew
capillary endothelial cells were slightly swollen 24 hr
afterbothcompounds, butnochangesweredetectedin
any cells of the alveolar epithelium.
Most of the compounds used to inhibit cytochrome
P-450isozymeactivityalsoprovidedsomedegreeofpro-
tectionagainstthetoxinsunderinvestigation(lible 1).
ProtectionbyOOSMeS canbe shownbothbythe 7-fold
reductionintheLD50ofOOSMeOandbytheprevention
of the increase in lung weights normally observed at 3
days(Thble2). TwohoursafterdosingwithOOSMeS, the
activity of lung microsomal pentoxyresorufin 0-
deethylase activity (PROD) was reduced by 90%. No
change inthe activity ofethoxyresorufin 0-deethylase
(EROD) was evident at this time, and neitherp-xylene
nor OOSMeS had any effect on cytochrome reductase
levels (Thble 3).
p-Xylene(at24hrafterdosing)inhibitedPROD, though
slightly less effectively than OOSMeS. p-Xylene, when
given 24 hr prior to challenge with OOSMeO, also gave
a 5-fold protection against the lung toxicity, i.e., it was
not quite as effective a protective agent as OOSMeS
(Thble 1).
This simple relationship between the inhibition of
PROD and protection doesnot, however, hold for other
toxins. OOSMeSonlygavelimitedprotectionagainstipo-
meanol, decreasing toxicity by approximately 2-fold;
whereasp-xylene decreased the toxicity of ipomeanol
8-fold (Table 1). p-Xylene prevented all signs of bron-
chiolar and alveolar injury 1, 2, and 3 days after ipo-
meanol (18 mg/kg). Rats given p-xylene, followed by a
much higher dose of ipomeanol (158 mg/kg), became
moribund3dayslater. Thebronchiolarepitheliumshow-
ed no signs of injury or recent repair at this time (Fig.
1B), but macroscopic examination suggested that the
liver had become the target organ. Pretreatment with
OOSMeSreducedboththe oralandintraperitoneal tox-
icityof 1-NNbyafactoroffour(ltble 1). Pseudocumene,
an aromatic hydrocarbon with properties similar to
p-xylene, was only able to reduce the toxicity of 1-NN
by a factor of two.
The trialkylphosphorothiolates 1-NN and ipomeanol
are all systemic lung toxins that are thought to require
activationbeforethey canproducetoxicity. There is no
evidencetosuggestthehepaticactivationofanyofthese
compoundswithsubsequentexportoftoxicmetabolites
tothelungs, andsothelungitselfisconsideredtobethe
activating organ.
A number of phosphorothionates that have been
showntopreventphosphorothiolate-inducedlunginjury
also inhibit 7-ethoxycoumarin 0-deethylase activity
(7-ECOD), particularlyinthelung(11). Severalaromatic
hydrocarbons including p-xylene and pseudocumene
reducetheconcentrationofcytochromeP-450inratlung
andalsoinhibit7-ECOD(19). Theactivityof7-ECODhas
been characterized in rat liver (20,21) and reflects the
neteffectofseveraldistinctisoenzymes. Despitethislack
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FIGURE 1. Rat bronchiolar epithelium: (A) 24 hr after the IP administration of ipomeanol (15 mg/kg) showing injury to both ciliated
and nonciliated cells; (B) 72 hr after the IP administration of ipomeanol (158 mg/kg) to an animal previously dosed with p-xylene
(1000 mg/kg). Bars = 5 ,um.
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Table 1. LD5, of toxins after various protective agents.a
Aromatic hydrocarbons
Protective agent/toxin Unprotected p-Xylene, IP Pseudocumene, IP OOSMeS, oral P-NF, oral
OOSMeO, oral 60 343 NDb 417 54
(51-71)C (242-488) (353-494) (39-74)
Ipomeanol, IP 18 159 ND 40 45d
(14-22) 133-190) (30-52)
1-NN, oral 299* ND 586 1067 398
(228-394) (477-719) (848-1343) (279-568)
1-NN, IP 138 ND ND 423 ND
(106-178) (298-602)
aEach group consisted of four rats, except *(10 rats). p-Xylene and pseudocumene (1000 mg/kg; 0.1 mL/100) were given 24 hr prior to
challenge: OOS-trimethylphosphorothiolate (OOSMeS) (12.5 mg/kg; 0.2 mL/100 g) was given 2 hr before challenge, and P-naphthoflavone
was given as three consecutive daily doses (3 x 80 mg/kg 1.0 mL/100 g) before challenge on day 4. Unprotected animals were given the
equivalent dose of arachis oil, the solvent used for all compounds.
bND, not determined.
cMilligram/kilogram body weight with 95% confidence limits.
dEstimated LD50 (45 mg/kg was maximum dose tested).
Table 2. Wet weight of lungs 3 days after the administration of each toxin to protected rats.a
Protective agent/toxin Unprotected p-Xylene, IP OOSMeS, oral P-NF, oral
OOSMeO, oral, 100 mg/kg 1046 754 606 996
(55) (54) (5) (8)
1-NN, oral, 173 mg/kg 928 NDb 568 ND
(104) (21)
'All compounds were dosed, as described in Table 1, to groups of five rats. Lung weights are expressed as mg/100 g body wt(± SEM) at
the time of challenge on day 0.
b ND = not determined.
Table 3. Enzyme activity of pulmonary microsomes (± SEM), prepared from rats given protective compounds and killed at the
normal time for toxic challenge.a
Protective compounds Pentoxyresorufin O-deethylase Ethoxyresorufin O-deethylase Cytochrome c-reductase
Arachis oil 21.4 1.9 22.0
(1.5) (0.28) (0.92)
OOSMeS, oral, 2hr 1.7 1.9 16.3
(0.21) (0.2) (0.94)
p-Xylene, IP, 24 hr 2.8 NDb 23.4
(0.6) (1.6)
Pseudocumene, IP, 24 hr 2.7 2.7 ND
(0.28) (0.16)
P-Naphthoflavone, oral, 4 days 16.4 27.6 ND
(1.6) (2.3)
aPentoxyresorufin and ethoxyresorufin are expressed as pmole/min/mg protein and cytochrome c reductase as nmole min/mg protein.
Compounds were dosed, as described in Table 1, to groups of five rats.
bND = not determined.
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ofspecificity, 7-ECOD isagood, overallindicatorofP-450
content in rat lung (22). Three P-450 isozymes have, so
far, beenidentifiedinratlung(23), cytochromes P-450b
ande, induciblebyphenobarbitone; andP-450c, induci-
ble by polycyclic aromatic hydrocarbons (23).
Pentoxyresorufin andethoxyresorufin aremuchmore
specificsubstratesthan 7-ethoxycoumarin (21). Pentoxy-
resorufinisparticularlyselectiveforP-450b(P-450IIB1)
(24), which is induced in liver by phenobarbitone (21).
Ethoxyresorufin isspecificforP-450c(P-450IA), which
is induced in liver by a number of polycyclic aromatic
hydrocarbons.
The selective inhibition of lung, but not liver, cyto-
chrome P-450byp-xylene andpseudocumene isthought
toresultfromthelackofalcohol dehydrogenaseinlung
(25,26). This organ, unlike the liver, is thus unable to
detoxify the p-methylbenzyl alcohol formed during
metabolism. p-Xylene may be metabolized to
p-methylbenzyl alcohol in the lung by P-4501IB1 and
probably also by other isozymes (26,27).
The alkylphosphorothionates probably inactivate
cytochrome P-450 by oxidation ofthe P=S moiety and
the subsequent covalent binding of atomic sulphur to
cytochrome P-450 (11). This inactivation can also occur
in the liver, but after an oral dose of OOSMeS (12.5
mg/kg), inhibition ofPROD is greater in the lung(92%)
thanintheliver(50%)(VerschoyleandDinsdale, unpub-
lished data). The pulmonary activity of P-450IA1
assessed as EROD isvery low, and it does not appearto
be involved inthe activationoftheselungtoxins. Some
oftheprotective aromatichydrocarbonsactuallyinduce
EROD (19,22). (3-Naphthoflavone, a potent inducer of
ERODwithnodetectableeffectonPROD(rlible3), gave
no protection against the toxicity of 1-NN or OOSMeO
(rlable 1). (3-Naphthoflavone onlyprovidedslight(2-fold)
protection against ipomeanoltoxicity, despite a 10-fold
inductionofERODinlungandprobably amuchgreater
induction in liver. This suggests that either a reduced
dose of ipomeanol is reaching the lung, owing to en-
hanced liver metabolism, or a very minor route ofpul-
monarydetoxification hasbeeninduced. Theinduction
ofafourthlungP-450isozymebyP-naphthoflavone(2?)
may account for this minor route of metabolism.
Thispresentstudyindicatesthattheprotectiveeffects
of both the aromatic hydrocarbons and the
trialkylphosphorothionates correlate, at least in part,
with their inhibition of PROD in the lung. Cytochrome
P-450IIB1 andotherisozymesareobviouslyvitalforthe
activationofeachpneumotoxin, althoughtheirrelative
contributions are still being investigated.
Theselectivesusceptibility ofalveolarcellstoOOSMeO
andOSSMeOwheninjurybyipomeanoland 1-NN(which
aresimilarly activatedbytheisozymes whichcomprise
PROD)islargelyrestrictedtothebronchiolarepithelium
also remains to be explored.
We are grateful for the generous gifts of compounds and also for
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